How to Control Nausea, Bloating, Burping, and Gas from Ozempic, Wegovy, Zepbound, Mounjaro GLP 1’s

by Dr. Richard Lipman MD
Board Certified in Internal Medicine/Endocrinology
Reviewed and Updated August 16, 2026

GLP-1’s injections and pills for weight loss are associated with significant, but controllable, gastrointestinal side effects. The overall incidence is 70% in most studies. GI side effects are similar when comparing Ozempic/Wegovy with Zepbound/Mounjaro(tirzepatide) and several compounded Semaglutides. They include nausea (44%), diarrhea(30%), vomiting(25%) , and constipation (24.2%). Less common are heartburn(including acid reflux, GERD, indigestion), burping, and non-specific abdominal pain.

MAXIMIZING WEIGHT LOSS WHILE MINIMIZING SIDE EFFECTS WHEN TAKING GLP-1 DRUGS

Understanding that these drugs affect the body in diverse ways can help the dieter maximize weight loss while minimizing the likelihood of side effects. Here are the areas where the dieter can influence side effects:

A. The dieter has control over the brain interactions of these drugs, especially the dose size and frequency of injections. All GLP-1s have a wide range of dosages. For example, Tirzepatide dosages can range from 0.625 mg to 15 mg a week. Wegovy doses can range from 0.25 mg to 7.2 mg a week. Then there’s the possibility of splitting doses within the week, which can cut side effects in half almost automatically. 

B. There is some ability to control the contribution of the pancreas’s release of insulin and glucagon secretion by limiting sugar and carb intake as much as possible. and increasing protein. This diet is low-carbohydrate, with 50 net carbs per day or less and 80 grams or more of protein or more per day.

C. Food and liquid choices and eating patterns are controllable: Understanding this can directly affect hunger and fullness while minimizing side effects.

The ability to reduce fat mass while preserving lean body mass, combined with their effects on lipid metabolism, glycemic control, and protein sparing, gives these medications a special place in weight loss.

GI Side Effects of GLP-1’s are Non-Serious, Mild to Moderate, and Transient, Observed in 33,000 Participants

In more than 11 studies of semaglutide treatment of both diabetic and non-diabetic obese individuals, these GI side effects occurred most frequently at the start of treatment and with dose escalation. Only 5% of participants discontinued the medication because of it, and almost all did so during the first few weeks of treatment. Some participants required a temporary dose reduction but quickly returned to their treatment dose. Thirty-nine studies covering more than 33,000 individuals are reported. Table 1 shows a summary from some of the studies, including the Tirzepatide and Semaglutide medications:

Table 1: Side Effects of GLP-1 Drugs:

Recent Observations show Nausea and Occasional Vomiting Usually Diminish as  Treatment continues.

Although the rates of nausea and vomiting remained higher in the semaglutide-treated individuals compared to the placebo group throughout all of the studies, this did not result in further dose reduction or permanent discontinuation of semaglutide treatment. Most recent observations reveal a gradual reduction in these symptoms after several weeks of treatment. See Graph 2 below.

Individuals in the semaglutide treatment group typically recovered from each GI event within a few days and resumed the medication. I have observed the same finding over the past 4 years in patients I have treated, regardless of which semaglutide they received. No one preparation exhibited consistently fewer side effects.  I have prescribed anti-emetics, fiber supplements, proton pump inhibitors (PPIs), and H2 blockers both intermittently and occasionally throughout the course of treatment, depending on individual reactions. No doubt the secret is to start low and go slow. One or two weeks on very low doses provides the patient with a lot of information and most often prevents future side effects.

Completion of Semaglutide and Tirzepatide Treatment Despite GI Side Effects

Almost all participants who reported GI side effects (96%) completed the study. This compares with those who completed the study and experienced no GI side effects. Even participants taking the highest dose of semaglutide (2.4 mg) in the Wegovy trials had a completion rate of 95%, similar to that of individuals without GI side effects (93%). This is consistent with the observation that most GI side effects can be avoided through gradual dose escalation and dose adjustments as the dose increases. This is true for Ozempic/Wegovy and Zepbound/Mounjaro dosing as well. 

GLP-1 Gastrointestinal Side Effects NOT the Cause of the Weight Loss

Although GLP-1 injections produce significant GI side effects, data from all studies show that the weight loss is attributable to the drug rather than to the side effects that might impair weight loss: nausea, vomiting, and diarrhea. This observation is supported because weight loss did not differ between subgroups experiencing GI side effects and those without.

This was seen in all of the studies and is precisely what I have encountered over the past 4 years. These observations should reassure both physicians and patients that the side effects of GLP-1 injections and pills are mild and transient. Their ability to lower weight is due to increased satiety, reduced appetite, diminished desire for carbohydrates and fatty foods, and reduced energy intake. This is mediated by the drug’s effect on brain appetite centers as well as directly on the stomach and pancreas.

GlP-1  Side Effects Only Partially Related to Higher Dosing

GLP-1 side effects are not entirely dose-related. Although some individuals can directly relate an increase in dosage to an increase in side effects, many others find little correlation, even with a tenfold rise in dose! Gradual dose escalation and especially dose adjustment can help mitigate the impact of the side effects. Almost all of the GI side effects can be avoided by microdosing, starting with doses of 0.6 to 1.25 mg of Tirzepatide and 0.125 mg of semaglutide for a week or two. These are very low doses. See Graph 1 for a comparison of side effects vs. dose. Note: doubling the dose of semaglutide from 0.05 to 1.0 mg increased weight loss by only 6-7 lbs.

                        Graph 1: Comparison of Weight Loss vs. Dose

                                                                                                                                                                                                                                                                 Constipation May Persist with GLP-1 Treatment     
Constipation may last longer than other GI side effects, consistent with the more chronic nature of this condition and the fact that it’s often due to other factors. Most commonly, it is due to a marked reduction in food intake, especially fatty foods and oils.

Pancreatitis and Gall Bladder Attacks:
Acute pancreatitis has been reported in patients treated with these medications. Patients should be observed for any signs and symptoms of acute pancreatitis (e.g., persistent severe abdominal pain). Trials have not shown an increased risk of pancreatitis with these medications, but it does exist with diabetics.

Cholelithiasis (gallstones) may occur with rapid weight loss on any diet, and an increased incidence has been reported in patients treated with Ozempic/Wegovy and Zepbound and Mounjaro for weight management. Appropriate clinical follow-up is required if gallstones are suspected.

Graphs 2 and 3 below show how side effects decrease by 30% over time and increase with dose.

How to Reduce Gastrointestinal Side Effects of GLP-1 Injections and Pills

Treating GI Side Effects by Changing Foods

No foods are strictly “off-limits” when taking GLP-1’s—in other words, there’s nothing to worry about that could prevent the medication from working normally. However, there are a few guidelines you’ll want to keep in mind to maximize weight loss and minimize GI side effects.

Fried foods and fatty foods, such as fast food, and foods high in sugar tend to be the toughest for your body to digest and the most likely to cause nausea. Patients taking Ozempic/Wegovy who experience nausea should consider the following tips:

1. Eat slowly, and eat smaller meals—stop when you feel full or even partially full!
2. Eat foods that are light and bland
3. Drink clear or ice-cold drinks (like water or unsweetened tea), avoid carbonated drinks
4. Avoid fried, greasy, or sweet foods

Treating GI Side Effects with OTC or Prescription Medications- Depends on Type of Symptoms

Nausea:
Nausea is clearly the most common GI side effect. It’s often seen at the very beginning and during dose escalation, but for most people, it becomes less and less significant over time. Studies have shown it’s due to delayed gastric emptying as well as the direct effect of these drugs on the brain.

Rx: OTC meds like Gas-X, Pepto-Bismol, Imodium, and prescription Zofran orally or Compazine by injection.

GERD-Heartburn-Reflux:
There is a transient worsening or new onset of gastroesophageal reflux disease (GERD; a known complication of obesity) during treatment for many patients.  Medications such as proton pump inhibitors or H2 Blockers can be used on a temporary basis.
Rx: Omeprazole, Prilosec- once or even twice a day to prevent reflux; for breakthrough pain, H2-blockers such as Pepcid AC, Tagamet, Protonix, Prevacid.

Constipation:
One of the most common side effects is due to the medication or, more likely, to changes in diet. Treatment includes standard management of constipation.

Rx: Fiber such as Metamucil capsules 2-3 twice a day with several glasses of water, stool softeners and/or Miralax.

Vomiting:
This less common side effect is usually transient and occurs more often in the initial phase rather than at higher doses.  Often treatment for GERD-like symptoms can stop the vomiting. If severe, then the antiemetics

Rx: OTC products: Dramamine, Bonine, Gravol, Pepto-Bismol, Emetrol,
prescription products include Zofran, Compazine, Phenergan

Pancreatitis, Gall Bladder Disease:
Both of these medical problems are much more serious than the non-specific symptoms due to gastric motility or GERD. Both consist of severe, recurrent pain, often radiating to the back. Anyone with severe pain needs to be fully evaluated, potentially including laboratory tests and/or diagnostic imaging. Obviously, GLP-1s should be discontinued and not restarted if pancreatitis is found.

Other Non- Related Causes
Clinicians should also consider whether any existing or recently initiated concomitant prescription or non-prescription medications could be responsible. For example, metformin can cause GI side effects.

Lowering the Dose of GLP-1’s:
Given the dose-dependent nature of these GI side effects, lowering the dose and/or delaying escalation should be considered for patients unable to tolerate the medications, to achieve a dose that allows them to gain at least some of the benefits with minimal GI side effects.

If GI symptoms occur and dose escalation is paused or the dose reduced, dose escalation can be retried once the patient is symptom-free at the lower dose. Such escalation should be slower than previously used. Many patients with GI side effects can reach the full dose, although the titration time may be longer than expected.

Other Causes of Abdominal Bloating, Burping, and Nausea Not Caused Directly by GLP-1’s

There are many possible causes of abdominal bloating, including fluid retention, irritable bowel syndrome, and infection. However, for most people, bloating is harmless and can be treated at home.

Abdominal bloating can be alarming, particularly when it is very painful. Some people notice that their belly looks swollen or misshapen, or they may experience sharp abdominal pain. Yet in many cases, the cause may be something as simple as indigestion or too much gas building up in the stomach and bowels, or, more likely, fatty foods.

How to control bloating and abdominal distention depends on the cause and severity. More than 20% of children and adults complain of bloating often associated with abdominal distention. Abdominal bloating can be a minor problem that most people have or a major source of pain and concern depending upon the cause. Here are some of the causes in Table 2.